Hideki Sasanuma

Tochigi, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 73 publications

Persistent FGFR pathway dependence: where does tinengotinib fit after FGFR inhibitor therapy in advanced cholangiocarcinoma?

Persistent FGFR pathway dependence: where does tinengotinib fit after FGFR inhibitor therapy in advanced cholangiocarcinoma?

Journal: Journal of gastrointestinal oncology

Published: June 16, 2026

Intraoperative warning signs of a cystic duct entering the right hepatic duct during laparoscopic cholecystectomy: a case report.

Intraoperative warning signs of a cystic duct entering the right hepatic duct during laparoscopic cholecystectomy: a case report.

Journal: Journal of surgical case reports

Published: May 21, 2026

Undifferentiated Carcinoma with Osteoclast-Like Giant Cells Associated with Carcinoma In Situ of the Main Pancreatic Duct.

Undifferentiated Carcinoma with Osteoclast-Like Giant Cells Associated with Carcinoma In Situ of the Main Pancreatic Duct.

Journal: Surgical case reports

Published: March 17, 2026

Synchronous Intra-ampullary Papillary-Tubular Neoplasm and Gallbladder Cancer.

Synchronous Intra-ampullary Papillary-Tubular Neoplasm and Gallbladder Cancer.

Journal: Cureus

Published: March 13, 2026

A Novel, Small-Incision, Gasless Videoscope-Assisted Necrosectomy for Infected Walled-Off Necrosis: A Single-Center Experience.

A Novel, Small-Incision, Gasless Videoscope-Assisted Necrosectomy for Infected Walled-Off Necrosis: A Single-Center Experience.

Journal: Journal of hepato-biliary-pancreatic sciences

Published: February 26, 2026

Diagnostic Biomarkers for Pancreatic Ductal Adenocarcinoma Using Non-Targeted Metabolomic Analysis.

Diagnostic Biomarkers for Pancreatic Ductal Adenocarcinoma Using Non-Targeted Metabolomic Analysis.

Journal: Cancers

Published: January 22, 2026

Real-world oncological and pathological outcomes after neoadjuvant chemotherapy with gemcitabine plus S-1 for resectable pancreatic cancer: A propensity score-matched cohort study.

Real-world oncological and pathological outcomes after neoadjuvant chemotherapy with gemcitabine plus S-1 for resectable pancreatic cancer: A propensity score-matched cohort study.

Journal: Surgical oncology

Published: January 11, 2026

High Pathological Response and Favorable Survival after Presurgical Sequential Lenvatinib-Transarterial Chemoembolization for Resectable Hepatocellular Carcinoma.

High Pathological Response and Favorable Survival after Presurgical Sequential Lenvatinib-Transarterial Chemoembolization for Resectable Hepatocellular Carcinoma.

Journal: Oncology

Published: September 30, 2025

Current status and characteristics of work-related musculoskeletal disorders among general surgeons in japan: a cross-sectional survey at a university hospital and its affiliated regional hospitals.

Current status and characteristics of work-related musculoskeletal disorders among general surgeons in japan: a cross-sectional survey at a university hospital and its affiliated regional hospitals.

Journal: Surgery today

Published: July 29, 2025

Prognostic Impact of Albumin Bilirubin Score In Patients Undergoing Surgery for Perihilar Cholangiocarcinoma.

Prognostic Impact of Albumin Bilirubin Score In Patients Undergoing Surgery for Perihilar Cholangiocarcinoma.

Journal: Anticancer research

Published: July 05, 2025

Sequential Fibroblast Growth Factor Receptor Inhibition in Intrahepatic Cholangiocarcinoma: Navigating an Evolving Landscape of Resistance and Opportunity-A Case Report and Current Opinion.

Sequential Fibroblast Growth Factor Receptor Inhibition in Intrahepatic Cholangiocarcinoma: Navigating an Evolving Landscape of Resistance and Opportunity-A Case Report and Current Opinion.

Journal: Oncology and therapy

Published: June 16, 2025

Metformin reshapes the tumor microenvironment and enhances prognosis in invasive pancreatic ductal adenocarcinoma with diabetes mellitus.

Metformin reshapes the tumor microenvironment and enhances prognosis in invasive pancreatic ductal adenocarcinoma with diabetes mellitus.

Journal: Journal of gastrointestinal oncology

Published: June 12, 2025

Showing 1-12 of 73

Last Updated: 09/26/2026